Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1984;63:776-780
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WEISS, P. A. M.
Right arrow Articles by LICHTENEGGER, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WEISS, P. A. M.
Right arrow Articles by LICHTENEGGER, W.

Gestational Diabetes and Screening During Pregnancy

P. A. M. WEISS, MD, H. HOFMAN, MD, R. WINTER, MD, P. PÜRSTNER, MD and W. LICHTENEGGER, MD

From the Department of Gynecology and Obstetrics, Graz University Medical School, Graz, Austria.

The oral glucose tolerance test is an unreliable test in screening for diabetogenic fetal disease. In diabetogenic fetopathy due to gestational diabetes (White class A diabetes), the insulin content in the umbilical cord blood as well as in the fetal urine is considerably raised. As increased amounts of insulin pass into the amniotic fluid via the fetal urine, the fetal disease can be diagnosed from the amniotic fluid insulin content. In 75 pregnant women with potential diabetes, the blood sugar value was below 160 mg/dL at maximum under glucose loading in 28 patients; it was over 200 mg/dL in 25 patients. However, diabetogenic fetopathy was present in only 14 patients. The endangered and the healthy fetus could be distinguished in each case by amniotic fluid insulin content. The mean amniotic fluid insulin values in diabetogenic fetopathy were about seven times the normal.




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. W. Carpenter, J. A. Canick, J. W. Hogan, C. Shellum, M. Somers, and J. A. Star
Amniotic Fluid Insulin at 14-20 Weeks' Gestation: Association with later maternal glucose intolerance and birth macrosomia
Diabetes Care, July 1, 2001; 24(7): 1259 - 1263.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. W. CARPENTER, J. A. CANICK, J. A. STAR, C. SHELLUM, and M. SOMERS
A High-Sensitivity Assay for Amniotic Fluid Insulin at 14-20 Weeks' Gestation
Obstet. Gynecol., November 1, 1999; 94(5): 778 - 782.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.